Aarkstore - Telomerase Activators -Pipeline Insights, 2014

1
Telomerase Activators -Pipeline Insights, 2014
Category Pharmaceuticals Healthcare 

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/76032/telomerase-activators-pipeline-insights-20
  14

2
Summary

• DelveInsights,Telomerase Activators-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  mechanism of action (MOA). A key objective of the
  report is to establish the understanding for all
  the pipeline drugs that fall under Telomerase
  Activators. This report provides information on
  the therapeutic development based on the
  Telomerase Activators dealing with mechanism of
  action, comparative analysis at various stages
  covering Filed, Phase III, Phase II, Phase I, IND
  filed, Preclinical, Discovery and unknown stages,
  therapeutics assessment by monotherapy and
  combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data SourcesThe report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by DelveInsight team of industry
  experts.Secondary sources information and data
  has been collected from various printable and
  non-printable sources like search engines, News
  websites, Government Websites, Trade Journals,
  White papers, Magazines, Trade associations,
  Books, Industry Portals, Industry Associations
  and access to available databases.Please note
  this report requires certain updates. We have all
  the information available but require 3 business
  days to complete the process and ensure it is as
  up-to-date as possible. Certain sections in the
  report may be removed or altered based on the
  availability and relevance of data for the
  indicated mechanism of action.

4
Summary

• Scope The report provides a snapshot of the
  global therapeutic landscape of Telomerase
  ActivatorsThe report provides pipeline products
  under drug profile section which includes product
  description, MOA, licensors collaborators,
  development partner and chemical
  informationCoverage of the Telomerase Activators
  pipeline on the basis of target, MOA, route of
  administration, technology involved and molecule
  typeThe report reviews key players involved in
  the therapeutics development for Telomerase
  Activators and also provide company profilingThe
  report also gives the information of dormant and
  discontinued pipeline projects Pipeline products
  coverage based on various stages of development
  ranging from preregistration till discovery and
  undisclosed stages Provides pipeline assessment
  by monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete MOA intelligence and
  complete understanding over therapeutics
  development for Telomerase ActivatorsIdentify
  the relationship between the drugs and use it for
  target finding, drug repurposing, and precision
  medicine.Devise corrective measures for pipeline
  projects by understanding Telomerase Activators
  pipeline depth and focus of Indication
  therapeutics Developing strategic initiatives to
  support your drug development activities.Optimize
  your portfolio and keep you in touch with the
  rapidly changing pharmaceutical markets, and make
  the best decisions for your business.

6

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and ScopeProvides
  strategically significant competitor information,
  analysis, and insights to formulate effective RD
  development strategies Modify the therapeutic
  portfolio by identifying discontinued projects
  and understanding the factors that drove them
  from pipelineGaining a Full Picture of the
  Competitive Landscape for Evidence based Decisions

Browse Complete Report - http//www.aarkstore.com/
pharmaceuticals-healthcare/76032/telomerase-activa
tors-pipeline-insights-2014
7
Table of Content

• Telomerase Activators OverviewTelomerase
  Activators Disease AssociatedTelomerase
  Activators Pipeline TherapeuticsTelomerase
  Activators Therapeutics under Development by
  Companies Telomerase Activators Late Stage
  Products (Filed and Phase III)Comparative
  Analysis Telomerase Activators Mid Clinical
  Stage Products (Phase II)Comparative
  Analysis Telomerase Activators Early Clinical
  Stage Products (Phase I and IND
  Filed)Comparative Analysis Telomerase
  Activators Discovery and Pre-Clinical Stage
  Products Comparative Analysis Drug Candidate
  Profiles
• Telomerase Activators Therapeutics
  Assessment Assessment by Monotherapy Products 

8
List of Tables

• Number of Products under Development for
  Telomerase Activators by Therapy Area,
  2014Number of Products under Development for
  Telomerase Activators, 2014Number of Products
  under Development by Companies Comparative
  Analysis by Late Clinical Stage Products (Filed
  and Phase III), 2014Comparative Analysis Mid
  Clinical Stage Products (Phase II),
  2014Comparative Analysis Early Clinical Stage
  Products (Phase I and IND Filed),
  2014Comparative Analysis Discovery and
  Pre-Clinical Stage Products, 2014Drug Candidates
  ProfilesTelomerase Activators Assessment by
  Monotherapy Products Telomerase Activators
  Assessment by Combination Products 

9
List of Tables

• Telomerase Activators Assessment by Route of
  Administration Telomerase Activators Assessment
  by Stage and Route of Administration Telomerase
  Activators Assessment by Molecule
  Type Telomerase Activators Assessment by Stage
  and Molecule Type Telomerase Activators
  Therapeutics Discontinued Products Telomerase
  Activators Therapeutics Dormant ProductsProducts
  under Development by Companies, 2014

10
List of Figures

• Number of Products under Development for
  Telomerase Activators by Therapy Area,
  2014Number of Products under Development for
  Telomerase Activators, 2014Late Clinical Stage
  Products (Filed and Phase III), 2014Mid Clinical
  Stage Products (Phase II), 2014Early Clinical
  Stage Products (Phase I and IND Filed),
  2014Discovery and Pre-Clinical Stage Products,
  2014Telomerase Activators Assessment by
  Monotherapy Products Telomerase Activators
  Assessment by Combination Products Telomerase
  Activators Assessment by Route of
  Administration Telomerase Activators Assessment
  by Stage and Route of Administration Telomerase
  Activators Assessment by Molecule
  Type Telomerase Activators Assessment by Stage
  and Molecule Type

11
Related Reports

• OncoPlex Diagnostics - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• MetaStat, Inc. - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Advanced Cell Diagnostics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Recordati S.p.A. (REC) - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Ascension Health - Pharmaceuticals Healthcare
  - Deals and Alliances Profile

12

• Telomerase Activators -Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights,Telomerase Activators-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  mechanism of action (MOA).
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
13
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news